HMGA2 and renal carcinoma: Huang et al [42] found that elevated levels of HMGA2 have been potentially linked to diminished overall survival among individuals diagnosed with head and neck cancer, hepatocellular carcinoma, renal cancer, and pancreatic ductal adenocarcinoma.